Moreover, behavioral disorders, oxidative stress, hyperphosphorylated tau protein, and amyloidosis symptoms were significantly improved in groups treated with 100 and 200 mg kg−1 doses of fucoidan. The gene discussed is MAPT; the disease is amyloidosis.